Skip to main content
B

BIONIME CORPORATION — Investor Relations & Filings

Ticker · 4737 TW Manufacturing
Filings indexed 1,731 across all filing types
Latest filing 2026-03-16 Regulatory Filings
Country TW Taiwan
Listing TW 4737

About BIONIME CORPORATION

https://www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
114年度營益分析
Regulatory Filings
2026-03-16 Chinese
114年第4季權益變動表
Regulatory Filings
2026-03-16 Chinese
114年第4季現金流量表
Regulatory Filings
2026-03-16 Chinese
114年第4季綜合損益表
Regulatory Filings
2026-03-16 Chinese
114年第4季資產負債表
Regulatory Filings
2026-03-16 Chinese
公告本公司董事會決議不分派股利
Regulatory Filings
2026-03-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.